Division of Becton Dickinson & Co.
Latest From SenoRx Inc.
The device industry is playing a pivotal role in the evolution toward a more personalized approach to breast cancer management, with ongoing advances in minimally invasive treatment systems, tumor characterization and breast imaging technologies adding to the momentum. In the years ahead, as the breast cancer toolbox expands, the watchword will be “choice,” with physicians and patients offered more treatment options, targeted to their specific needs and desires, than ever before.
- Diagnostic Equipment & Supplies
Diagnostic Imaging Equipment & Supplies
- MRI, NMR
Surgical Equipment & Devices
- Minimally or Less Invasive
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- Becton Dickinson & Co.
- Senior Management
Kevin J Cousins, VP, Fin. & CFO
William F Gearhart, VP, Global Mktg. & Corp. Dev.
Paul Lubock, VP, CTO
- Contact Info
Phone: (949) 362-4800
Irvine, CA 92618
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.